1. Technological advancements in microarray technology leading to increased efficiency and accuracy of gene expression analysis.
2. Rising demand for personalized medicine and targeted therapy, driving the adoption of microarray techniques in healthcare.
3. Growing applications of microarrays in research fields such as genomics, proteomics, and diagnostics, leading to expanded opportunities in the market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Type, Application, End User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Illumina,, Agilent Technologies,, Thermo Fisher Scientific,, Merck & Co.,, PerkinElmer,, Arrayit, Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, Affymetrix |
1. High cost associated with purchasing and maintaining microarray equipment and reagents, limiting adoption among smaller research facilities.
2. Lack of skilled professionals adept at using microarray technology, hindering widespread implementation and utilization in various industries.